31P-MRS of Muscle Pathophysiology

  • Kevin McCully
  • Krista Vandenborne
  • Glenn Walter
  • William Bank


Muscle fatigue and weakness are common clinical complaints, the underlying causes of which are often difficult to determine. The advent of 31P-MRS has provided a powerful tool to identify and study muscle disease.1 Indeed, some of the first in vivo studies employing 31P-MRS were studies of muscle pathologies.2,3 This chapter will review some of the muscle pathologies that have been studied using 31P-MRS.


Chronic Fatigue Syndrome Duchenne Muscular Dystrophy Muscle Energy Metabolism Phosphorus Magnetic Resonance Spectroscopy Creatine Kinase Equilibrium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Radda GK, Rajagopalan B, Talyor DJ. Biochemistry in vivo: an appraisal of clinical magnetic resonance spectroscopy. Magn Reson Q 1989;5:122–151.PubMedGoogle Scholar
  2. 2.
    Chance B, Eleff S, Bank W, et al. 31P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle. Proc Natl Acad Sci USA 1982;79:7714–7718.PubMedCrossRefGoogle Scholar
  3. 3.
    Gadian DG, Radda RK, Ross BD, et al. 31P NMR examination of a myopathy. Lancet 1981;2:744–775.Google Scholar
  4. 4.
    Chance B, Leigh JS, Kent J, et al. Multiple controls of oxidative metabolism of living tissues as studied by 31-P MRS. Proc Natl Acad Sci USA 1986;83:9458–9462.PubMedCrossRefGoogle Scholar
  5. 5.
    Bertocci LA, Haller RG, Lewis SF, et al. Abnormal high-energy phosphate metabolism in human muscle phospho-fructokinase deficiency. J Appl Physiol 1991;70:1201–1207.PubMedGoogle Scholar
  6. 6.
    Blei ML, Conley KE, Kushmerick MJ. Separate measures of ATP ultilization and recovery in human skeletal muscle. J Physiol (Lond) 1993;456:203–222.Google Scholar
  7. 7.
    Kemp GJ, Radda GK. Quantitative interpretation of bio-energetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Mag Res Quart 1994;10:43–63.Google Scholar
  8. 8.
    Adams GR, Foley JM, Meyer RA. Muscle buffer capacity estimated from pH changes during rest-to-work transitions. J Appl Physiol 1990;69:968–972.PubMedGoogle Scholar
  9. Bank W, Argov Z, Leigh JS, Chance B. The value of 31P NMR in the diagnosis and monitoring the course of human myopathies. Ann NY Acad Sci 1986:448–450.Google Scholar
  10. 10.
    Argov Z, Bank WJ, Maris J, et al. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987; 37:257–262.PubMedGoogle Scholar
  11. 11.
    McCully K, Vandenborne K, De Meirleir K, et al. Muscle metabolism in track athletes using 31-P magnetic resonance spectroscopy. Can J Physiol Pharmacol 1992;70:1353–1359.PubMedCrossRefGoogle Scholar
  12. 12.
    Barbiroli B, Funicello R, Iotti S, et al. 31P NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/ BMD carriers: altered rate of phosphate transport. J Neurol Sci 1992;109:188–195.PubMedCrossRefGoogle Scholar
  13. 13.
    Lewis SF, Haller RC. The pathophysiology of McArdle’s disease: clues to regulation in exercise and fatigure. J Appl Physiol 1986;61:391–401.PubMedGoogle Scholar
  14. 14.
    Taylor DJ, Styles P, Matthews PM, et al. Energetics of human muscle; exercise induced ATP depletion. Magn Reson Med 1986;3:44–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Argov Z, Bank WJ, Maris J, et al. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy. Ann Neurol 1987;16:529–538.Google Scholar
  16. 16.
    Goelman G, Walter G, Leigh JS Jr. Hadamard spectroscopic imaging technique as applied to study human calf muscles. Magn Reson Med 1992;25:349–354.PubMedCrossRefGoogle Scholar
  17. 17.
    McCully KK, Kent JA, Chance B. Muscle injury and exercise stress measured with 31-P magnetic resonance spectroscopy. In: Paul R, Elzinga G, Yamada K, eds. Muscle energetics. Progress in clinical and biological research, vol. 315.1989:197–207. New York, Alan RLiss, Inc.Google Scholar
  18. 18.
    McArdle B. Myopathies due to a defect in muscle glycogen breakdown. Clin Sci 1951;10:13–35.Google Scholar
  19. 19.
    Argov Z, Bank WJ, Boden B, et al. Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis: an in vivo study of phosphoglycerate mutase deficiency. Arch Neurol 1987;44:614–617.PubMedGoogle Scholar
  20. 20.
    Giger U, Argov Z, Schnall M, et al. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency. Muscle Nerve 1988;11:1260–1265.PubMedCrossRefGoogle Scholar
  21. 21.
    Eleff S, Kennaway NG, Buist NRM, et al. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 1984;81:3529–3533.PubMedCrossRefGoogle Scholar
  22. 22.
    Argov Z, Bank WJ, Maris J, et al. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: a 31P-NMR follow-up study. 1986;19:598–602.Google Scholar
  23. 23.
    Wilson JR, Fink L, Maris J, et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985;71:57–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Wiener DH, Fink LI, Maris J, et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986;73:1127–1136.PubMedCrossRefGoogle Scholar
  25. 25.
    McCully KK, Posner JD. Measuring exercise-induced adaptations and injury with magnetic resonance spectroscopy. Int J Sports Med 1992;13(Suppl 1):S147–S149.PubMedCrossRefGoogle Scholar
  26. 26.
    Barbiroli G, Montagna P, Cortelli P, et al. Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia 1990;10:264–272.CrossRefGoogle Scholar
  27. 27.
    Hands L, Bore P, Galloway B, et al. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy. Clin Sci 1986;71:283–290.PubMedGoogle Scholar
  28. 28.
    Keller U, Oberhansli R, Huber P, et al. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. Eur J Clin Invest 1985;15:382–388.PubMedCrossRefGoogle Scholar
  29. 29.
    Zatina M, Berkowitz H, Gross G, et al. 31-P nuclear magnetic resonance spectroscopy: noninvasive biochemical analysis of the ischemic extremity. J Vase Surg 1986;3: 411–420.Google Scholar
  30. 30.
    Younkin DP, Berman P, Sladky J, et al. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 1987;37:165–169.PubMedGoogle Scholar
  31. 31.
    McCully KK, Argov Z, Boden BP, et al. Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy. Muscle Nerve 1988;11:212–216.PubMedCrossRefGoogle Scholar
  32. 32.
    Griffiths RD, Cady EB, Edwards RH, Wilkie DR. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no efffect of allopurinol or ribose. Muscle Nerve 1985;8:760–767.PubMedCrossRefGoogle Scholar
  33. 33.
    Barbiroli B, Funicello R, Iotti S, et al. Muscle energy metabolism in female DMD/BMD carriers: altered rate of phosphate transport. J Neurol Sci 1992;109:188–195.PubMedCrossRefGoogle Scholar
  34. 34.
    Schluederberg A, Straus SE, Peterson P, et al. Chronic fatigue syndrome research: definition and medical outcome assessment. Ann Intern Med 1992;117:325–331.PubMedGoogle Scholar
  35. 35.
    Kent-Braun JA, Sharma K, Massie B, et al. Absence of metabolic abnormalities in patients with chronic fatigue syndrome. Neurology 1993;43:125–131.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Kevin McCully
  • Krista Vandenborne
  • Glenn Walter
  • William Bank

There are no affiliations available

Personalised recommendations